74385-37-8

Basic information

• Product Name: Methyl 4-fluoro-3-Methoxybenzoate
• Synonyms: Methyl 4-fluoro-3-Methoxybenzoate
• CAS NO: 74385-37-8
• Molecular Formula: C₉H₉FO₃
• Molecular Weight: 184.1643632
• Mol File: 74385-37-8.mol
• Article Data: 13

Chemical Properties

• Melting Point: 40 °C(Solv: ethanol (64-17-5))
• Boiling Point: 250.5°C at 760 mmHg
• Flash Point: 102.2°C
• Appearance: /
• Density: 1.184g/cm³
• Vapor Pressure: 0.0216mmHg at 25°C
• Refractive Index: 1.486
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 4-fluoro-3-Methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-fluoro-3-Methoxybenzoate(74385-37-8)
• EPA Substance Registry System: Methyl 4-fluoro-3-Methoxybenzoate(74385-37-8)

Safety Data

• Hazardous Substances Data: 74385-37-8(Hazardous Substances Data)

Usage

General Description

Methyl 4-fluoro-3-methoxybenzoate is a chemical compound with the molecular formula C9H9FO3. It is a flavoring and fragrance agent that is commonly used in the production of perfumes, cosmetics, and personal care products. Methyl 4-fluoro-3-Methoxybenzoate is also known for its potential pharmaceutical applications, particularly in the development of anti-inflammatory and anti-microbial drugs. Methyl 4-fluoro-3-methoxybenzoate is a clear, colorless liquid with a sweet, fruity odor, and it is typically synthesized through esterification reactions involving 4-fluoro-3-methoxybenzoic acid and methanol. Methyl 4-fluoro-3-Methoxybenzoate should be handled and stored with appropriate safety precautions due to its potential hazards if mishandled.

InChI:InChI=1/C9H9FO3/c1-12-8-5-6(9(11)13-2)3-4-7(8)10/h3-5H,1-2H3

Upstream product

• 41608-64-4 methyl 3-methoxy-4-aminobenzoate 
• 67-56-1 methanol 
• 82846-18-2 4?fluoro-3-methoxybenzoic acid 
• 51446-31-2 4-fluoro-3-hydroxybenzoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 159768-50-0 methyl 4-fluoro-5-methoxy-2-nitrobenzoate 
• 568584-57-6 methyl 4-(4-aminopiperidin-1-yl)-3-methoxybenzoate 
• 247035-43-4 4-(4-azido-piperidin-1-yl)-3-methoxy-benzoic acid methyl ester 
• 247035-44-5 methyl 4-{4-(methanesulfonyloxy)piperidin-1-yl}-3-methoxybenzoate 
• 247035-45-6 methyl 3-methoxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoate 
• 247035-46-7 3-methoxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoic acid 
• 247034-74-8 (2S)-benzenesulfonylamino-3-[3-hydroxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoylamino]propionic acid 
• 247034-71-5 tert-butyl (2S)-benzenesulfonylamino-3-[3-methoxy-4-{4-(pyrimidin-2-ylamino)piperidin-1-yl}benzoylamino]propionate 
• 869475-52-5 7-fluoro-6-methoxyquinazolin-4-ol 
• 159768-48-6 4-chloro-7-fluoro-6-methoxyquinazoline 
• 159768-51-1 2-amino-4-fluoro-5-methoxybenzoic acid methyl ester 
• 162012-60-4 4-(3-chloro-4-fluoroanilino)-6-methoxy-7-fluoroquinazoline 

Relevant articles and documents

Pyrazole derivative for FGFR inhibitor and preparation method of pyrazole derivative

The invention provides a pyrazole derivative for an FGFR inhibitor and a preparation method of the pyrazole derivative. The invention specifically relates to an amide pyrazole compound serving as an FGFR irreversible inhibitor, and a preparation method and application thereof. The present invention provides a compound as shown in Formula I, or a pharmaceutically acceptable salt, or solvate, isotope substitute, prodrug, or metabolite thereof. The compound as shown in general formula I have FGFR inhibitory activity, and is capable of preventing or treating disorders associated with FGFR activityor expression, preferably such as cancer.

BICYCLIC ETHER O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS

Described herein are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables Ar, X, R1, R3, R 4, Y1, Y2, n and p are as defined herein.

Pyrazolo [3,4 - the b] pyridine and [...] composition preparation method and use of (by machine translation)

The present invention provides a pyrazolo [3,4 - the b] pyridine and [...] compound of preparation and use, in particular, the present invention provides a following formula (I) compounds are shown, wherein the definition of each group as described in the specification. The compounds of the invention has excellent tyrosine kinase inhibiting activity, so can be used for preparing a series of treating diseases associated with the tyrosine kinase activity of the drug. (by machine translation)